Immuneering Corporation Granted FDA Fast Track Designation for IMM-1-104 in First-Line Pancreatic Cancer.
Oncology Company Granted FDA Fast Track Designation For Pancreatic Cancer Treatment Development
Oncology Company Granted FDA Fast Track…
Oncology Company Granted FDA Fast Track Designation For Pancreatic Cancer Treatment Development
Immuneering Corporation Granted FDA Fast Track Designation for IMM-1-104 in First-Line Pancreatic Cancer.